Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI
Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis
Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis
View: Text | PDF
Research Article Aging Immunology

ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI

  • Text
  • PDF
Abstract

The mechanisms utilized by differentiating B cells to withstand highly damaging conditions generated during severe infections, like the massive hemolysis that accompanies malaria, are poorly understood. Here, we demonstrate that ROCK1 regulates B cell differentiation in hostile environments replete with pathogen-associated molecular patterns (PAMPs) and high levels of heme by controlling 2 key heme-regulated molecules, BACH2 and heme-regulated eIF2α kinase (HRI). ROCK1 phosphorylates BACH2 and protects it from heme-driven degradation. As B cells differentiate, furthermore, ROCK1 restrains their pro-inflammatory potential and helps them handle the heightened stress imparted by the presence of PAMPs and heme by controlling HRI, a key regulator of the integrated stress response and cytosolic proteotoxicity. ROCK1 controls the interplay of HRI with HSP90 and limits the recruitment of HRI and HSP90 to unique p62/SQSTM1 complexes that also contain critical kinases like mTOR complex 1 and TBK1, and proteins involved in RNA metabolism, oxidative damage, and proteostasis like TDP-43. Thus, ROCK1 helps B cells cope with intense pathogen-driven destruction by coordinating the activity of key controllers of B cell differentiation and stress responses. These ROCK1-dependent mechanisms may be widely employed by cells to handle severe environmental stresses, and these findings may be relevant for immune-mediated and age-related neurodegenerative disorders.

Authors

Juan Rivera-Correa, Sanjay Gupta, Edd Ricker, Danny Flores-Castro, Daniel Jenkins, Stephen Vulcano, Swati P. Phalke, Tania Pannellini, Matthew M. Miele, Zhuoning Li, Nahuel Zamponi, Young-Bum Kim, Yurii Chinenov, Eugenia Giannopoulou, Leandro Cerchietti, Alessandra B. Pernis

×

Figure 1

B cell ROCK1 regulates humoral responses during TD immunization.

Options: View larger image (or click on image) Download as PowerPoint
B cell ROCK1 regulates humoral responses during TD immunization.
(A–E) W...
(A–E) WT (black) and Cg1-Rock1 (orange) mice were immunized intraperitoneally (ip) with 100 mg NP-CGG for 7–28 days as indicated. Pooled quantifications of germinal center (GC) B cells (A; B220+GL7+Fas+), NP-specific B cells (B; B220+IgM–IgD–Gr1–IgG1+NP+), NP-specific GC B cells (C; B220+IgM–IgD–Gr1–IgG1+NP+CD38lo) from WT and Cg1-Rock1 mice as assessed by flow cytometry. Data pooled from 7 WT and 6 Cg1-Rock1 mice across 2 independent experiments and show mean ± SEM; P value by unpaired 2-tailed t tests. (D) ELISA data showing relative concentrations of NP<8-IgG1 and NP>25-IgG1 in the serum of the indicated mice at days 0–28 after immunization. Data pooled from 4 mice at day 14 and 8 mice from days 0, 21, and 28 per genotype across 2 independent experiments and show mean ± SEM; P value by 2-way ANOVA followed by Holm-Šídák test for multiple comparisons. (E–H) WT or CD23-Rock1 mice were immunized ip with 100 μg NP-CGG, and GC B cells (B220+GL7+CD38lo) were sorted at day 7 for bulk RNA-Seq. Data shown are from 3 independent experiments. (E) GSEA plot shows the downregulation of the REACTOME_CHOLESTEROL_BIOSYNTHESIS pathway in CD23-Rock1 GC B cells. (F) Dot plot shows the top enriched HALLMARK pathways upregulated in CD23-Rock1 GC B cells as compared with WT GC B cells at FDR < 0.1. (G) GSEA plot showing the enrichment of the HALLMARK_TNFA_signaling_via_NFKB in CD23-Rock1 GC B cells. (H) Heatmap of the z-score–scaled expression of genes enriching the HALLMARK Inflammatory response pathway in CD23-Rock1 GC B cells. *P value < 0.05, **P value < 0.01, ***P value < 0.001, and ****P value < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts